A Phase 2 interventional study of Papillex® in HPV-related cervical abnormalities
Recruiting Not Applicable NCT06979180
Study Description
Investigating the effects of Papillex® on abnormal cervical cells caused by HPV
Study Details
- Registry ID:
- NCT06979180
- Conditions:
- CIN - Cervical Intraepithelial Neoplasia, CIN 1, CIN 2, HPV, Cervical Cells
- Phase:
- Not Applicable
- Target Enrollment:
- 60 participants
- Start Date:
- Age Range:
- 25–55 years
- Gender:
- Female
- Healthy Volunteers:
- No
Study Locations (1 site)
-
KGK Science Inc.
London, Ontario, Canada
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.